Nationwide Fund Advisors’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Nationwide Fund Advisors’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6	Closed	-$8K	–	3276
2015 Q4	$8K	Hold	6	–	–	﹤0.01%	3161
2015 Q3	$9K	Hold	6	–	–	﹤0.01%	3196
2015 Q2	$14K	Hold	6	–	–	﹤0.01%	3187
2015 Q1	$18K	Buy	6 +1	+20%	+$3.2K	﹤0.01%	3187
2014 Q4	$18K	Hold	5	–	–	﹤0.01%	3106
2014 Q3	$17K	Hold	5	–	–	﹤0.01%	3186
2014 Q2	$19K	Sell	5 -14	-74%	-$52.7K	﹤0.01%	3159
2014 Q1	$75K	Hold	19	–	–	﹤0.01%	2811
2013 Q4	$72K	Hold	19	–	–	﹤0.01%	3026
2013 Q3	$76K	Buy	19 +1	+6%	+$7.5K	﹤0.01%	2999
2013 Q2	$181K	Buy	+18	New	+$199K	﹤0.01%	2532

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Nationwide Fund Advisors's FRTX Position: Q1 2016 in Review

Nationwide Fund Advisors sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2016, closing a stake of 6 shares — an estimated $8K sold.

Nationwide Fund Advisors first reported a position in FRTX in Q2 2013 and held it in 11 quarters. The position peaked at $181K in Q2 2013. 43 funds tracked by Wall St. Rank hold FRTX as of Q1 2016.

Nationwide Fund Advisors reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 6 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $8K.
Nationwide Fund Advisors first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
Nationwide Fund Advisors's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $181K in Q2 2013.
43 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Nationwide Fund Advisors's 13F filing for Q1 2016, filed 5 May 2016.